Valid Ghana · FDA Ghana

BLUE MAP DNS​ ​INTRAVENOUS INFUSION

Sodium Chloride BP/ GlucoseAnhydrous

FDA/SD.255-010044 Sodium Chloride BP/ GlucoseAnhydrous 0.9%w/v / 5% w/v

What it does

Glucose anhydrous is a simple sugar used to provide quick energy to the body.

Commonly used for: low blood sugar (hypoglycemia), energy supplementation

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/SD.255-010044
Registration date
2025-01-12
Expiry date
2029-12-01
Status
Valid
Active ingredient
Sodium Chloride BP/ GlucoseAnhydrous
Dosage form
Sodium Chloride BP/ GlucoseAnhydrous
Strength
0.9%w/v / 5% w/v
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Kamla Amrut Pharmaceutical
Applicant / LTR
Entrance Pharmaceuticals & Research Centre - No 16 Okpoi Gonno, Spintex Road, Accra-Ghana
Country of origin
-
Manufacturer location
Kamla Amrut Industrial Park Opp Torrent Pharma, Indrad, Kadi, Indrad, Gujarat 384440, India

Source: Food and Drugs Authority · fetched 2026-04-18 08:42:15 · updated 2026-10-20 04:00:12

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.

About this medicine

Glucose anhydrous is a simple sugar used to provide quick energy to the body.

What it treats

  • low blood sugar (hypoglycemia)
  • energy supplementation

How it works

Glucose anhydrous quickly increases the level of sugar in the blood, giving the body an immediate source of energy.

Who it's for

It is suitable for people who need a quick boost of energy or have low blood sugar levels.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: glucoseanhydrous

Glucose anhydrous is a simple sugar and carbohydrate, primarily used as a source of energy in biological systems. It is a white crystalline powder that is highly soluble in water and is used in various medical and nutritional applications, including rehydration solutions and as a sweetener in food products. Its rapid absorption and metabolism make it suitable for immediate energy needs.

Indications

  • Hypoglycemia
  • Energy supplementation in malnutrition
  • Rehydration therapy in dehydration
  • As a carbohydrate source in parenteral nutrition

Dosage

Children: Refer to the specific clinical guidelines or formularies for appropriate dosing based on the indication and patient condition.

Adults: Refer to the specific clinical guidelines or formularies for appropriate dosing based on the indication and patient condition.

Mechanism of action

Glucose anhydrous is absorbed through the intestinal wall into the bloodstream, where it raises blood glucose levels. It is then taken up by various cells in the body via glucose transporters, primarily GLUT1 and GLUT4, which facilitate its entry into muscle and adipose tissues. Once inside the cells, glucose undergoes glycolysis and is metabolized to produce ATP, the energy currency of the cell.

Pharmacodynamics

The pharmacodynamic properties of glucose anhydrous relate to its role in energy metabolism. Upon ingestion, it causes a rapid increase in blood glucose levels, which stimulates insulin secretion from the pancreas. Insulin promotes the uptake of glucose by cells, thereby lowering blood glucose levels back to normal. This process is critical for maintaining homeostasis, particularly during fasting or strenuous physical activity.

Pharmacokinetics

Glucose anhydrous is rapidly absorbed from the gastrointestinal tract, with peak plasma concentrations occurring within 30 minutes to 2 hours after ingestion, depending on the formulation and presence of other nutrients. It is primarily metabolized in the liver and muscle tissues. The elimination half-life is not well defined, as glucose is continuously utilized for energy or stored as glycogen. The renal excretion of glucose may occur when blood levels exceed the renal threshold, typically above 180 mg/dL.

Adverse effects

  • Hyperglycemia
  • Dehydration
  • Electrolyte imbalance
  • Nausea
  • Vomiting
  • Diarrhea

Precautions

  • Use with caution in patients with diabetes mellitus
  • Monitor blood glucose levels regularly
  • Caution in patients with renal impairment
  • Use cautiously in patients with electrolyte disturbances

Pregnancy

Generally considered safe, but should be used under medical supervision.

Breast-feeding

Considered safe, but consult a healthcare provider.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

  • Oral powder
  • Oral solution
  • Intravenous solution
PubChem / pathway

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.